RT Journal Article
SR Electronic
T1 Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006136
DO 10.1136/jitc-2022-006136
VO 11
IS 1
A1 Lemech, Charlotte
A1 Dredge, Keith
A1 Bampton, Darryn
A1 Hammond, Edward
A1 Clouston, Andrew
A1 Waterhouse, Nigel J
A1 Stanley, Amanda C
A1 Leveque-El Mouttie, Lucie
A1 Chojnowski, Grace M
A1 Haydon, Andrew
A1 Pavlakis, Nick
A1 Burge, Matthew
A1 Brown, Michael P
A1 Goldstein, David
YR 2023
UL http://jitc.bmj.com/content/11/1/e006136.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.